Arjun Goyal's most recent trade in Centessa Pharmaceuticals plc - ADR was a trade of 40,000 Share Option (right to buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals p... | Arjun Goyal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 40,000 | 40,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Arjun Goyal | Director | Purchase of securities on an exchange or from another person at price $ 12.73 per share. | 15 May 2025 | 417,646 | 462,585 | - | 12.7 | 5,315,005 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Arjun Goyal | Director | Purchase of securities on an exchange or from another person at price $ 12.24 per share. | 15 May 2025 | 44,939 | 44,939 | - | 12.2 | 550,238 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Arjun Goyal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 48,000 | 48,000 | - | - | Share Option (right to buy) |